Shares of Cancer Genetics Inc (NASDAQ:CGIX) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.18 and traded as low as $0.16. Cancer Genetics shares last traded at $0.17, with a volume of 2,383 shares trading hands.
The firm’s 50 day simple moving average is $0.18. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24.
Cancer Genetics (NASDAQ:CGIX) last released its quarterly earnings results on Monday, May 20th. The medical research company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $6.84 million for the quarter. Cancer Genetics had a negative net margin of 77.28% and a negative return on equity of 175.72%.
About Cancer Genetics (NASDAQ:CGIX)
Cancer Genetics, Inc develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, Europe, and Asia. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biotech and pharmaceutical companies involved in oncology and immuno-oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics.
Recommended Story: What is the Coverage Ratio?
Receive News & Ratings for Cancer Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cancer Genetics and related companies with MarketBeat.com's FREE daily email newsletter.